| Outcome . | Donor sperm IVF/ICSI N = 17 634 . | Partner sperm IVF/ICSI N = 308 920 . | Donor versus partner Unadjusted OR (95% CI) . | Donor versus partner Adjusted OR (95% CI) . | ||
|---|---|---|---|---|---|---|
| n . | % . | n . | % . | . | . | |
| Biochemical Pregnancy | 2057 | 11.7 | 40 342 | 13.1 | 0.88 (0.84–0.92) | 0.82 (0.78–0.86) |
| Miscarriage | 2778 | 15.8 | 49 499 | 16.0 | 0.98 (0.94–1.02) | 0.93 (0.89–0.97) |
| Ectopic pregnancy | 177 | 1.0 | 4580 | 1.5 | 0.67 (0.58–0.78) | 0.77 (0.66–0.90) |
| Molar pregnancy | 0 | 0.0 | 68 | 0.0 | – | – |
| Termination | 122 | 0.7 | 1873 | 0.6 | 1.14 (0.95–1.37) | 1.01 (0.84–1.23) |
| Embryo reduction | 26 | 0.1 | 296 | 0.1 | 1.54 (1.03–2.30) | 1.31 (0.86–1.99) |
| Still birth | 92 | 0.5 | 1581 | 0.5 | 1.02 (0.83–1.26) | 1.02 (0.82–1.27) |
| Live birth | 12 828 | 72.7 | 218 896 | 70.9 | 1.10 (1.06–1.14) | 1.17 (1.13–1.21) |
| Outcome . | Donor sperm IVF/ICSI N = 17 634 . | Partner sperm IVF/ICSI N = 308 920 . | Donor versus partner Unadjusted OR (95% CI) . | Donor versus partner Adjusted OR (95% CI) . | ||
|---|---|---|---|---|---|---|
| n . | % . | n . | % . | . | . | |
| Biochemical Pregnancy | 2057 | 11.7 | 40 342 | 13.1 | 0.88 (0.84–0.92) | 0.82 (0.78–0.86) |
| Miscarriage | 2778 | 15.8 | 49 499 | 16.0 | 0.98 (0.94–1.02) | 0.93 (0.89–0.97) |
| Ectopic pregnancy | 177 | 1.0 | 4580 | 1.5 | 0.67 (0.58–0.78) | 0.77 (0.66–0.90) |
| Molar pregnancy | 0 | 0.0 | 68 | 0.0 | – | – |
| Termination | 122 | 0.7 | 1873 | 0.6 | 1.14 (0.95–1.37) | 1.01 (0.84–1.23) |
| Embryo reduction | 26 | 0.1 | 296 | 0.1 | 1.54 (1.03–2.30) | 1.31 (0.86–1.99) |
| Still birth | 92 | 0.5 | 1581 | 0.5 | 1.02 (0.83–1.26) | 1.02 (0.82–1.27) |
| Live birth | 12 828 | 72.7 | 218 896 | 70.9 | 1.10 (1.06–1.14) | 1.17 (1.13–1.21) |
Adjusted for maternal age, pregnancy history, number of embryos transferred, IVF or ICSI, fresh or frozen cycle, and causes of infertility (unexplained, tubal factor, ovulatory disorder, male factor, endometriosis) and year of treatment.
OR: odds ratio.
| Outcome . | Donor sperm IVF/ICSI N = 17 634 . | Partner sperm IVF/ICSI N = 308 920 . | Donor versus partner Unadjusted OR (95% CI) . | Donor versus partner Adjusted OR (95% CI) . | ||
|---|---|---|---|---|---|---|
| n . | % . | n . | % . | . | . | |
| Biochemical Pregnancy | 2057 | 11.7 | 40 342 | 13.1 | 0.88 (0.84–0.92) | 0.82 (0.78–0.86) |
| Miscarriage | 2778 | 15.8 | 49 499 | 16.0 | 0.98 (0.94–1.02) | 0.93 (0.89–0.97) |
| Ectopic pregnancy | 177 | 1.0 | 4580 | 1.5 | 0.67 (0.58–0.78) | 0.77 (0.66–0.90) |
| Molar pregnancy | 0 | 0.0 | 68 | 0.0 | – | – |
| Termination | 122 | 0.7 | 1873 | 0.6 | 1.14 (0.95–1.37) | 1.01 (0.84–1.23) |
| Embryo reduction | 26 | 0.1 | 296 | 0.1 | 1.54 (1.03–2.30) | 1.31 (0.86–1.99) |
| Still birth | 92 | 0.5 | 1581 | 0.5 | 1.02 (0.83–1.26) | 1.02 (0.82–1.27) |
| Live birth | 12 828 | 72.7 | 218 896 | 70.9 | 1.10 (1.06–1.14) | 1.17 (1.13–1.21) |
| Outcome . | Donor sperm IVF/ICSI N = 17 634 . | Partner sperm IVF/ICSI N = 308 920 . | Donor versus partner Unadjusted OR (95% CI) . | Donor versus partner Adjusted OR (95% CI) . | ||
|---|---|---|---|---|---|---|
| n . | % . | n . | % . | . | . | |
| Biochemical Pregnancy | 2057 | 11.7 | 40 342 | 13.1 | 0.88 (0.84–0.92) | 0.82 (0.78–0.86) |
| Miscarriage | 2778 | 15.8 | 49 499 | 16.0 | 0.98 (0.94–1.02) | 0.93 (0.89–0.97) |
| Ectopic pregnancy | 177 | 1.0 | 4580 | 1.5 | 0.67 (0.58–0.78) | 0.77 (0.66–0.90) |
| Molar pregnancy | 0 | 0.0 | 68 | 0.0 | – | – |
| Termination | 122 | 0.7 | 1873 | 0.6 | 1.14 (0.95–1.37) | 1.01 (0.84–1.23) |
| Embryo reduction | 26 | 0.1 | 296 | 0.1 | 1.54 (1.03–2.30) | 1.31 (0.86–1.99) |
| Still birth | 92 | 0.5 | 1581 | 0.5 | 1.02 (0.83–1.26) | 1.02 (0.82–1.27) |
| Live birth | 12 828 | 72.7 | 218 896 | 70.9 | 1.10 (1.06–1.14) | 1.17 (1.13–1.21) |
Adjusted for maternal age, pregnancy history, number of embryos transferred, IVF or ICSI, fresh or frozen cycle, and causes of infertility (unexplained, tubal factor, ovulatory disorder, male factor, endometriosis) and year of treatment.
OR: odds ratio.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
